Trials / Completed
CompletedNCT02462083
Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque Psoriasis
A Phase 3, Multicenter, Open Label Study to Evaluate the Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque Psoriasis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 555 (actual)
- Sponsor
- Bausch Health Americas, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate the long-term safety of IDP-118 lotion.
Detailed description
This is a multicenter, open-label study of the long-term safety of IDP-118 lotion in participants with plaque psoriasis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | IDP-118 Lotion | IDP-118 lotion will be applied as per the instructions provided by the investigational center staff. |
Timeline
- Start date
- 2015-08-11
- Primary completion
- 2017-01-31
- Completion
- 2017-04-24
- First posted
- 2015-06-03
- Last updated
- 2020-01-27
- Results posted
- 2020-01-27
Locations
46 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02462083. Inclusion in this directory is not an endorsement.